American Century Companies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

American Century Companies’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-214,592	Closed	-$5.12M	–	1768
2019 Q4	$5.12M	Buy	214,592 +76,337	+55%	+$2.11M	﹤0.01%	805
2019 Q3	$3.71M	Buy	138,255 +8,279	+6%	+$232K	﹤0.01%	864
2019 Q2	$3.53M	Buy	129,976 +39,429	+44%	+$1.24M	﹤0.01%	911
2019 Q1	$3.14M	Buy	+90,547	New	+$2.61M	﹤0.01%	922
2018 Q3	–	Sell	-80,698	Closed	-$3.05M	–	1386
2018 Q2	$3.05M	Buy	80,698 +6,383	+9%	+$244K	﹤0.01%	942
2018 Q1	$2.43M	Buy	74,315 +13,667	+23%	+$600K	﹤0.01%	969
2017 Q4	$2.95M	Buy	60,648 +9,275	+18%	+$469K	﹤0.01%	946
2017 Q3	$2.78M	Sell	51,373 -1,867	-4%	-$110K	﹤0.01%	981
2017 Q2	$2.99M	Buy	53,240 +1,407	+3%	+$56.4K	﹤0.01%	970
2017 Q1	$2.03M	Buy	51,833 +19,460	+60%	+$620K	﹤0.01%	1038
2016 Q4	$726K	Buy	32,373 +3,216	+11%	+$62.8K	﹤0.01%	1193
2016 Q3	$662K	Sell	29,157 -13,586	-32%	-$319K	﹤0.01%	1231
2016 Q2	$1.01M	Sell	42,743 -5,791	-12%	-$143K	﹤0.01%	1135
2016 Q1	$990K	Sell	48,534 -14,771	-23%	-$469K	﹤0.01%	1102
2015 Q4	$3.26M	Buy	63,305 +10,580	+20%	+$513K	﹤0.01%	938
2015 Q3	$2.25M	Buy	52,725 +12,307	+30%	+$594K	﹤0.01%	1002
2015 Q2	$1.84M	Buy	40,418 +8,896	+28%	+$358K	﹤0.01%	1042
2015 Q1	$1.2M	Sell	31,522 -3,308	-9%	-$114K	﹤0.01%	1123
2014 Q4	$986K	Buy	34,830 +1,519	+5%	+$42.2K	﹤0.01%	1190
2014 Q3	$842K	Buy	33,311 +1,782	+6%	+$46.9K	﹤0.01%	1214
2014 Q2	$920K	Buy	+31,529	New	+$763K	﹤0.01%	1233

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

American Century Companies's PTLA Position: Q1 2020 in Review

American Century Companies sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 214,592 shares — an estimated $5.12M sold.

American Century Companies first reported a position in PTLA in Q2 2014 and held it in 21 quarters. The position peaked at $5.12M in Q4 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

American Century Companies reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
American Century Companies sold 214,592 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $5.12M.
American Century Companies first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 21 quarters.
American Century Companies's Portola Pharmaceuticals, Inc. position peaked at $5.12M in Q4 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on American Century Companies's 13F filing for Q1 2020, filed 14 May 2020.